Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Feasibility Study of the Bios Device for Continuous Glucose Monitoring in Subjects With Type 1 or Type 2 Diabetes Mellitus

NCT04226846 is registered in ClinicalTrials.gov with GraphWear Technologies Inc. as lead sponsor.

NCT NCT04226846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04226846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Feasibility Study of the Bios Device for Continuous Glucose Monitoring in Subjects With Type 1 or Type 2 Diabetes Mellitus
Lead sponsor
GraphWear Technologies Inc.
Phase
Observational
Overall status
Unknown status
Start date
December 9, 2019
Completion date
March 15, 2020
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes, type 2 diabetes